Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03461718 · ClinicalTrials.gov registry record · Phase 2
Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.
A Phase 2 study, sponsored by Brooke Army Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT03461718 is a Phase 2 study that has completed, run by Brooke Army Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT03461718, a Phase 2 study, has completed, sponsored by Brooke Army Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
We will be investigating the use of ketamine in sedation for endoscopic procedures, specifically outpatient endoscopy including esophagoduodenoscopy (EGD) and colonoscopy. Participants will be randomized to one of two arms including conventional moderate sedation with midazolam and fentanyl or the ketamine arm. They will then undergo the planned procedure. Physicians preforming the procedure will be surveyed following the procedure and patients will be surveyed twice, once after meeting criteria for discharge on day of the procedure and a second time 48 hours following the procedure.
Interventions
- DRUG Ketamine
- DRUG Fentanyl
- DRUG Midazolam injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2019-10-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03461718
The ClinicalTrials.gov registry entry for NCT03461718 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT03461718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03461718 about?
NCT03461718 is a clinical study titled "Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.". We will be investigating the use of ketamine in sedation for endoscopic procedures, specifically outpatient endoscopy including esophagoduodenoscopy (EGD) and colonoscopy. Participants will be randomized to one of two arms including conventional moderate sedation with midazolam and fentanyl or the k...
What is the current status of trial NCT03461718?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2018-03-05. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03461718?
The interventions under investigation include: Ketamine (DRUG), Fentanyl (DRUG), Midazolam injection (DRUG).
Who is sponsoring clinical trial NCT03461718?
This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.